Abstract
Abstract
Background
European countries face fiscal pressure regarding the long-term sustainability of their healthcare system due to increasing levels of public health expenditures and mounting demographic pressures. The promotion of generic drugs is considered to be an efficient means to tackle these challenges; however, market diffusion remains slow. The aim of this study was to investigate the impact of price and brand cues on purchase intentions by means of Direct-to-Consumer (DTC) advertising, and to build on the market cue evaluation model by Dodd et al.
Methods
Participants rated purchase intentions on six DTC adverts varying in price and brand information, followed by self-reports on purchase intentions, attitudes towards generics, brand loyalty, price consciousness, as well as perceptions of quality, risk and value. Open-ended questions explored attitudes toward generic drugs.
Results
Brand information and purchase intentions were mediated by perceived risk and perceived quality, while price information influenced purchase intention through perceptions of quality, risk and value. Consumers’ purchase behaviour was furthermore influenced by unawareness and misconceptions, past experiences, and advertising as a decision-making tool.
Conclusions
Advertisements, including price and brand information, are an important tool to improve consumers’ awareness of the availability of different OTC drugs. Practical and theoretical implications are discussed.
Funder
Health Services Research Programme
Publisher
Springer Science and Business Media LLC
Reference66 articles.
1. Ugalmugale S, Swain R. Global market insights: over-the-counter drugs market share 2019–2025 trends growth report. 2019. https://www.gminsights.com/industry-analysis/over-the-counter-otc-drugs-market.
2. Menshausen S. Germany Trade and Invest Gesellschaft für Außenwirtschaft und Standortmarketing mbH (Hrsg.). Energiewirtschaft 2008 VR China, Köln. 2009.
3. Greer SL. The three faces of European Union health policy: policy, markets, and austerity. Policy Soc. 2014;33(1):13–24.
4. Simoens S. Creating sustainable European health-care systems through the increased use of generic medicines: a policy analysis. J Gener Med. 2010;7(2):131–7.
5. Bongers F, Carradinha H. How to increase patient access to generic medicines in European healthcare systems. EGA Health Economics Committee, European Generic medicines Association. 2009.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献